Abstract LB-150: Risk of <i>de novo</i> hepatocellular carcinoma development following use of direct acting antiviral medications for treatment of chronic hepatitis C virus infection

Authors: Samuel O. Antwi, Holly K. Van Houten, Lindsey R. Sangaralingham, Tushar Patel

Published: 2019-08-07

DOI: 10.1158/1538-7445.am2019-lb-150

Source: Full article